Literature DB >> 25467253

Analysis of the prevalence of dyslipidemia in individuals with HIV and its association with antiretroviral therapy.

Talita Gabriela de Limas1, Gustavo de Araujo Pinto2, Liz Miriane Marcato1, Daniel Reszel Coelho1.   

Abstract

INTRODUCTION: Antiretroviral therapy (ART) has been used to treat large numbers of patients living with human immunodeficiency virus (HIV) infection. Lipid disorders are often observed in these patients, and include elevations in total cholesterol (TC) and triglycerides (TG).
METHODS: A cross-sectional study was performed using 333 patient records from the Regional Hospital of São José Doutor Homero de Miranda Gomes (HRSJHMG). The study population consisted of patients with HIV who were under medical follow up, either on or off drug treatment. The data were entered into Excel and exported to SPSS 16.0 for analysis using chi-square testing. We used prevalence ratios as the measure of association.
RESULTS: Lipid abnormalities were observed in 78.9% of individuals who received ART. Of the 308 subjects on ART, 59.1%, 41.9%, and 33.1% had TG, TC and low-density lipoprotein (LDL) abnormalities, respectively. The prevalence of LDL changes was 2.57-fold higher in individuals who had been using ART for more than 12 months, compared to those using ART for 6 to 12 months.
CONCLUSIONS: HIV patients showed a significant increase in the association between TC and TG levels and the use of ART. In particular, changes in TC, LDL and TG were greater in individuals who had received ART for over more than 12 months.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25467253     DOI: 10.1590/0037-8682-0128-2014

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  5 in total

1.  Dyslipidemia and Associated Factors Among Adult Patients on Antiretroviral Therapy in Armed Force Comprehensive and Specialized Hospital, Addis Ababa, Ethiopia.

Authors:  Adnan Kemal; Melese Sinaga Teshome; Kalkidan Hassen Abate; Mohammed Ahmed; Meseret Molla; Tabarak Malik; Jemmal Mohammed
Journal:  HIV AIDS (Auckl)       Date:  2020-07-02

2.  [Prevalence, associated and predisposing factors of metabolic syndrome among people living with HIV on antiretroviral treatment in Porto Novo in 2014].

Authors:  Alassani Adébayo; Dovonou Comlan Albert; Sossou Ericie; Attinsounon Cossi Angelo; Gninkoun Jules; Wanvoegbe Armand; Ahoui Séraphin; Codjo Léopold; Ade Gabriel
Journal:  Pan Afr Med J       Date:  2015-11-24

3.  Association of single nucleotide polymorphisms with dyslipidemia in antiretroviral exposed HIV patients in a Ghanaian population: A case-control study.

Authors:  Christian Obirikorang; Emmanuel Acheampong; Lawrence Quaye; Joseph Yorke; Ernestine Kubi Amos-Abanyie; Priscilla Abena Akyaw; Enoch Odame Anto; Simon Bannison Bani; Evans Adu Asamoah; Emmanuella Nsenbah Batu
Journal:  PLoS One       Date:  2020-01-13       Impact factor: 3.240

4.  Research priorities for accelerating the achievement of three 95 HIV goals in Cameroon: a consensus statement from the Cameroon HIV Research Forum (CAM-HERO).

Authors:  Anastase Dzudie; Boris Tchounga; Rogers Ajeh; Charles Kouanfack; Peter Vanes Ebasone; Tatiana Djikeussi; Léonard Bonono Nyoto; Joseph Fokam; Jérôme Ateudjieu; Patrice Tchendjou; Ezechiel Ngoufack Jagni Semengue; Fabrice Youbi Kamgang; Jean Anoubessi; Marie Varloteaux; Boris Youngui; Felicite Naah Tabala; Benjamin Atanga; Leonie Simo; Armel Zemsi; Emile Nforbih Shu; Gilles Ndayisaba; Annereke Nyenti; Apungwa Cornelius Ntabe; Therese Abong Bwemba; Eugene Sobngwi; Serge Clotaire Billong; John Ditekemena; Anne Cecile Zoung-Kanyi Bissek; Louis Richard Njock
Journal:  Pan Afr Med J       Date:  2021-10-29

5.  Dyslipidemia in people living with HIV-AIDS in a tertiary hospital in South-East Nigeria.

Authors:  Ernest Ndukaife Anyabolu
Journal:  Pan Afr Med J       Date:  2017-11-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.